Genetic analysis and putative role in resistance to antivirals of the human cytomegalovirus DNA polymerase UL44 processivity factor

Antiviral Therapy

Volumn 14, Issue 6, 2009, Pages 847-852

  Boutolleau, David ^a,b   Deback, Claire ^a,b   Bressollette Bodin, Céline ^c,d   Conan, Françoise ^b   Aït Arkoub, Zaïna ^b   Imbert Marcille, Berthe Marie ^c,d   Agut, Henri ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔTEL DIEU   (France)

^d UFR Sciences Pharmaceutiques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIVIRUS AGENT; DNA POLYMERASE; PROTEIN UL44; PROTEIN UL54; PROTEIN UL97; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANTIVIRAL RESISTANCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DNA SYNTHESIS; DRUG TREATMENT FAILURE; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN CYTOMEGALOVIRUS; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS STRAIN;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; DNA-BINDING PROTEINS; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, VIRAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; VIRAL PROTEINS;

EID: 72049098525     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1299     Document Type: Article

References (20)

1. Chou S. Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev Med Virol 2008; 18:233-246. (Pubitemid 352018847)
2. Chou S, Lurain NS, Thompson KD, Miner RC, Drew WL. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. J Infect Dis 2003; 188:32-39. (Pubitemid 36829739)
3. Weiland KL, Oien NL, Homa F, Wathen MW. Functional analysis of human cytomegalovirus polymerase accessory protein. Virus Res 1994; 34:191-206. (Pubitemid 24360574)
4. Pari GS, Kacica MA, Anders DG. Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLytdependant DNA synthesis. J Virol 1993; 67:2575-2582.
5. Ripalti A, Boccuni C, Campanini F, Landini MP. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J Virol 1995; 69:2047-2057.
6. Appleton BA, Loregian A, Filman DJ, Coen DM, Hogle JM. The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol Cell 2004; 15:233-244. (Pubitemid 38950970)
7. Appleton BA, Brooks J, Loregian A, Filman DJ, Coen DM, Hogle JM. Crystal structure of the cytomegalovirus DNA polymerase subunit UL44 in complex with the C terminus from the catalytic subunit. J Biol Chem 2006; 281:5224-5232.
8. Loregian A, Appleton BA, Coen DM, Hogle JM. Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44. J Virol 2004; 78:158-167. (Pubitemid 37549728)
9. Loregian A, Appleton BA, Hogle JM, Coen DM. Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit. J Virol 2004; 78:9084-9092. (Pubitemid 39096519)
10. Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS. Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit. J Virol 2003; 77:8336-8344. (Pubitemid 36871462)
11. Krosky PM, Baek MC, Jahng WJ, et al. The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J Virol 2003; 77:7720-7727.
12. Woon HG, Scott GM, Yiu KL, Miles DH, Rawlinson WD. Identification of putative functional motifs in viral proteins essential for human cytomegalovirus DNA replication. Virus Genes 2008; 37:193-202.
13. Boutolleau D, Deback C, Bressollette-Bodin C, et al. Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection. Antiviral Res 2009; 81:174-179.
14. Dolan A, Cunningham C, Hector RD, et al. Genetic content of wild-type human cytomegalovirus. J Gen Virol 2004; 85:1301-1312. (Pubitemid 38659794)
15. Chou S, Lurain S, Weinberg A, et al. Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Antimicrob Agents Chemother 1999; 43:1500-1502. (Pubitemid 29259354)
16. Fillet AM, Aurey L, Alain S, et al. Natural polymorphism of cytomegalovirus DNA polymerase lies in two nonconserved regions located between domains delta-C and II and between III and I. Antimicrob Agents Chemother 2004; 48:1865-1868. (Pubitemid 38544399)
17. Pari GS, Anders DG. Eleven loci encoding transacting factors are required for transient complementation of human cytomegalovirus oriLyt-dependant DNA replication. J Virol 1993; 67:6979-6988.
18. Komazin-Meredith G, Petrella R, Santos WL, et al. The human cytomegalovirus UL44 C clamp wraps around DNA. Structure 2008; 16:1214-1225.
19. Alvisi G, Jans DA, Guo J, Pinna LA, Ripalti A. A protein kinase CK2 site flanking the nuclear targeting signal enhances nuclear transport of human cytomegalovirus ppUL44. Traffic 2005; 6:1002-1013. (Pubitemid 41472459)
20. Loregian A, Coen DM. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase. Chem Biol 2006; 13:191-200. (Pubitemid 43255591)